UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.
UniBio has raised $3.2M in total funding. The most recent round was Series B. The last funding was announced in February 2024.
UniBio's investors include Niigata Venture Capital.
UniBio is headquartered in Niigata, Japan.
UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.
UniBio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"UniBio — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/unibio. Accessed September 30, 2026.
VCBacked. (2024). UniBio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/unibio
{{cite web |title=UniBio — Funding & Investors |url=https://www.vcbacked.co/company/unibio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated